• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

Global Blockchain Congress: Innovations and Investments in Web3 and Digital Assets

user avatar

by Giorgi Kostiuk

a year ago


The Global Blockchain Congress (GBC) is a platform leveraging blockchain innovators with leading investors. The event, held in Dubai, Vietnam, the UK, and Singapore, draws attention due to its significant investments and successful projects.

International Experience and Achievements

The Congress has been held 13 times in Dubai and internationally in Vietnam, the UK, and Singapore. These events attracted over 1,600 investors and 360+ startups, with total investments amounting to millions of dollars, highlighting the success of the gatherings.

Key Topics and Discussions

During the event, key topics include Dubai's role as a hub for Web3 and digital assets, building a sustainable and growing Web3 industry, and the convergence of blockchain and AI in transforming innovations. Fund-raising for crypto projects and tokenizing personal data and digital identity are also discussed.

Goals and Format of the Event

GBC's mission is to foster collaboration and innovation through one-on-one meetings between projects and investors. The event will host over 150 investors, 25 projects, 60 A-list speakers, and 30 media partners.

The Global Blockchain Congress remains a leading venue for discussions and meetings, aiming at shaping the future of blockchain technology through investment and innovation.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Converge Bio's AI Platform Aims to Transform Drug Development

chest

Converge Bio is leveraging its newly acquired $25 million funding to enhance its AI platform, which focuses on drastically reducing the time and costs associated with drug development.

user avatarKenji Takahashi

Converge Bio Secures $25 Million Series A Funding to Transform Drug Discovery

chest

Converge Bio, a startup based in Boston and Tel Aviv, has raised $25 million in Series A funding to enhance AI-driven drug discovery.

user avatarMaria Fernandez

Buterin Continues Charity Donations from Token Sales

chest

Vitalik Buterin continues his practice of selling unsolicited tokens and donating the proceeds to charity, emphasizing ethical considerations in cryptocurrency promotions.

user avatarRajesh Kumar

Vitalik Buterin Sells Unsolicited Tokens for 94 ETH

chest

Ethereum cofounder Vitalik Buterin has sold unsolicited tokens from his wallet, converting them into 94 ETH.

user avatarGustavo Mendoza

Grayscale Segments Crypto Market into Five Vertical Categories

chest

Grayscale has categorized its altcoin candidates into five verticals, reflecting a structured approach to the crypto market.

user avatarMiguel Rodriguez

Decline in FLOW Price Amid Controversial Asset Recovery

chest

The price of FLOW has seen a significant decline following the Flow project's controversial asset recovery actions.

user avatarLuis Flores

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.